BGN New English<BGN News (Eng)< BGN News
BGN NEWS ENGLISH
>   Gil Weiser appointed Chairman of the Board of Directors of BGN Technologies
>   BGU to Co-Found Renewable Energy Center
>   Prima-Fuel and BGU to Collaborate in Developing Renewable Fuels from Algae
>   ExxonMobil and BGU to develop an "on-board" Hydrogen production system
>   Neuroderm raises $2.5M for transdermal Parkinson's treatment
>   BotanoCap raises $1M for environmental friendly pesticide technology
>   Multipon, developer of optical networks equipment based on technology from BGU, raised 4.7 M NIS
>   Protea, a new start-up company, is established based on vaccine technology from BGU
>   BiolineRX to develop anti-inflamatory drug based on technology from BGU
>   Invitrogen to collaborate with BGU in improving drug development processes
/Resources/Eng/BGN1/News/BGN english/$^$^$
BiolineRX to develop anti-inflamatory drug based on technology from BGU
Prima-Fuel and BGU to Collaborate in Developing Renewable Fuels from Algae
ExxonMobil and BGU to develop an "on-board" Hydrogen production system
BotanoCap raises $1M for environmental friendly pesticide technology
BGU to Co-Found Renewable Energy Center
Multipon, developer of optical networks equipment based on technology from BGU, raised 4.7 M NIS
Invitrogen to collaborate with BGU in improving drug development processes
Neuroderm raises $2.5M for transdermal Parkinson's treatment
Protea, a new start-up company, is established based on vaccine technology from BGU
Gil Weiser appointed Chairman of the Board of Directors of BGN Technologies